首页> 外国专利> Methods for functional kidney imaging using small dendrimer contrast agents

Methods for functional kidney imaging using small dendrimer contrast agents

机译:使用小型树状大分子造影剂进行功能性肾脏成像的方法

摘要

Small dendrimer-based MRI contrast agents are disclosed to accumulate in renal tubules. The accumulation enables visualization of renal structure and function, permitting assessment of structural and functional damage to the kidneys. In a disclosed embodiment, six, small dendrimer-based MRI contrast agents were synthesized, and their pharmacokinetics, whole body retention, and renal MRI images were evaluated in mice. Surprisingly, despite having unequal renal clearance properties, all of the dendrimer agents clearly visualized the renal anatomy and proximal straight tubules of the mice better than Gd-[DTPA]-dimeglumine. Dendrimer conjugate contrast agents prepared from PAMAM-G2D, DAB-G3D, and DAB-G2D dendrimers were excreted rapidly and may be acceptable for use in clinical applications.
机译:公开了基于小树枝状聚合物的MRI造影剂,它们会积聚在肾小管中。积累能够使肾脏的结构和功能可视化,从而可以评估肾脏的结构和功能损伤。在一个公开的实施方案中,合成了六种基于小树状聚合物的MRI造影剂,并在小鼠中评估了它们的药代动力学,全身滞留和肾脏MRI图像。令人惊讶地,尽管具有不相等的肾脏清除特性,但所有树状聚合物试剂都清楚地显示了小鼠的肾脏解剖结构和近端直小管,优于Gd-lsDTb-dimeglumine。由PAMAM-G2D,DAB-G3D和DAB-G2D树枝状大分子制备的树枝状大分子共轭造影剂被迅速排泄,在临床应用中可能是可接受的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号